EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma

Tareq Nayef AlRamadneh, Renuka Jyothi S, Priya Priyadarshini Nayak, Anima Nanda, Shaker Al Hasnaawei, Akanksha Bhatt, Ashish Singh Chauhan, Siya Singla, Mehrdad Nourizadeh

Brain and Behavior · 2026

DOI: 10.1002/brb3.71648 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Brain and Behavior, 2026. Verfasst von Tareq Nayef AlRamadneh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center For Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Gastrointestinal Microbiome, Neuroinflammatory Diseases. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults and remains difficult to treat because of diffuse invasion, immunosuppression, metabolic adaptability, and therapy resistance. This review evaluates how gut microbiota and microbiota‐associated neuroinflammatory signaling may contribute to GBM biology and therapeutic response.

Method

We synthesized mechanistic, preclinical, translational, and emerging clinical evidence on microbiota‐neuroinflammation interactions in GBM. The review focused on gut‐brain axis pathways, microbial metabolites, blood‐brain barrier (BBB) regulation, glial and myeloid immune activity, tumor‐associated microbial signatures, microbial peptide‐HLA presentation, and microbiome‐informed biomarker or therapeutic strategies. Finding Current evidence suggests that microbiota‐related signals may influence GBM through systemic immune modulation, short‐chain fatty acids, tryptophan‐derived metabolites, polyamines, BBB effects, and altered microglial and tumor‐associated myeloid cell function. Polyamine metabolism may sustain myeloid‐cell‐mediated immunosuppression in the acidic GBM tumor microenvironment, whereas microglial GLUT5‐dependent fructose metabolism may limit inflammatory antigen presentation and adaptive antitumor immunity. Sequencing‐based studies have reported bacterial and fungal nucleic acid signatures in brain tumor specimens, but these findings require careful interpretation because of low biomass, contamination risk, and methodological variability. Preclinical models further indicate that microbiome modulation can alter inflammatory tone, tumor growth, immune‐cell infiltration, and response to immune checkpoint blockade.

Conclusion

Microbiota‐regulated neuroinflammation is a biologically plausible contributor to GBM progression, immune suppression, and treatment resistance. However, most evidence remains preclinical or early translational. Well‐controlled, spatially resolved, multi‐omic studies are required before microbiome‐based biomarkers or interventions can be clinically implemented for patient stratification and future precision clinical neuro‐oncology applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsGastrointestinal MicrobiomeNeuroinflammatory DiseasesHumansAnimalsTumor MicroenvironmentBlood-Brain BarrierInflammation

Stichwörter der Autor:innen

glioblastomagut–brain axisimmunotherapymicrobiota‐derived metabolitesneuroinflammationtumor microenvironment

Autor:innen und Institutionen

  • Faculty of Allied Medical Sciences, Hourani Center For Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan.
  • Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to Be University), Bangalore, Karnataka, India.
  • Department of Medical Oncology, IMS and, SUM Hospital, Siksha 'O' Anusandhan, Bhubaneswar, Odisha, India.
  • Department of Biomedical, Sathyabama Institute of Science and Technology, Chennai, Tamil Nadu, India.
  • College of Pharmacy, The Islamic University, Najaf, Iraq.
  • Department of Medical Analysis, Medical Laboratory Technique College, The Islamic University of Al Diwaniyah, Al Diwaniyah, Iraq.

Zitieren

APA

AlRamadneh, T. N., S, R. J., Nayak, P. P., Nanda, A., Hasnaawei, S. A., Bhatt, A., Chauhan, A. S., Singla, S., & Nourizadeh, M. (2026). Microbiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma. Brain and Behavior. https://doi.org/10.1002/brb3.71648

Vancouver

AlRamadneh TN, S RJ, Nayak PP, Nanda A, Hasnaawei SA, Bhatt A, et al. Microbiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma. Brain and Behavior. 2026. doi:10.1002/brb3.71648

BibTeX
@article{AlRamadneh2026,
  author = {AlRamadneh, Tareq Nayef and S, Renuka Jyothi and Nayak, Priya Priyadarshini and Nanda, Anima and Hasnaawei, Shaker Al and Bhatt, Akanksha and Chauhan, Ashish Singh and Singla, Siya and Nourizadeh, Mehrdad},
  title = {Microbiota–Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma},
  journal = {Brain and Behavior},
  year = {2026},
  doi = {10.1002/brb3.71648}
}
Kostenlos starten →